Screening after hypertensive pregnancy disorders: She can do best

A gut feeling about children’s exposure to hypertensive disorders of pregnancy in utero

“…The use of modern eHealth applications for self-measurement of blood pressure at home might pack a punch for postpartum follow-up in these women and offer an advantage compared to incidental measurements at the physician's office. 13 To conclude, every systematic review in the field of children's exposure to hypertensive disorders of pregnancy in utero agrees with the statement of the paucity of relevant published high-quality studies. On the other hand, all these studies demonstrated that children carry a cardiovascular risk profile.…”

Impact of preventive screening and lifestyle interventions in women with a history of preeclampsia: A micro-simulation study

“…Nevertheless, some young women may be willing to take medication when becoming aware of their CVD risk after having suffered from preeclampsia. 47 For example, the proportion of women that answered ‘yes’ to the question ‘Do you have a prescription of preventive medication?’ in the initial cardiovascular screening is around 19% (see Supplemental Material Appendix C). Additionally, a notable proportion had health complaints due to hypertension shortly after pregnancy, making it more likely that they would be willing to use medical therapy, even at their young age.…”

“…Additionally, a notable proportion had health complaints due to hypertension shortly after pregnancy, making it more likely that they would be willing to use medical therapy, even at their young age. 47,48 Further research on the optimal (age-dependent) combination of lifestyle interventions, preventive medication or other preventive interventions (e.g. self-monitoring with e-health applications), and the actual adherence to these interventions should be conducted.…”

“…Nevertheless, some young women may be willing to take medication when becoming aware of their CVD risk after having suffered from preeclampsia. 47 For example, the proportion of women that answered 'yes' to the question 'Do you have a prescription of preventive medication?' in the initial cardiovascular screening is around 19% (see Supplemental Material Appendix C).…”

Editor’s presentation: ‘Accreditation and certification. A step towards optimising quality’

“…This population may benefit from primary prevention strategies and a healthy lifestyle approach directed at the whole family after pregnancy. 6,7 Obesity paradox in heart failure: still a matter of debate While intentional weight loss is known to improve haemodynamic function and cardiac structure in the general population, and obesity is an independent risk factor for cardiovascular disease development, 8 in heart failure patients the association of obesity and improved survival has been repeatedly observed. In the present issue, it is claimed that obesity defined by body mass index (BMI) or by percentage body fat (PBF), is characterised by better prognosis and lower plasma N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) in heart failure patients, but not by a reduction in highsensitivity troponin T (hs-TnT) and soluble suppression of tumorigenesis-2 (sST2).…”